Benign Prostatic Hyperplasia

Metabolic Syndrome and BPH

Prostate growth in men with benign prostatic hyperplasia (BPH) is increased in the presence of the metabolic syndrome, according to a study that supports a causative role for hyperinsulinemia.

BPH Treatment Device Returns to Market

Celsion Corporation of Columbia, Md., has announced it will resume shipments of its Prolieve Thermodilatation system for benign prostatic hyperplasia after clearance from the FDA’s Center for Devices and Radiological Health.

Outpatient HoLEP Safe for BPH

CLEVELAND—Outpatient holmium laser enucleation (HoLEP) of the prostate for treating BPH is safe and feasible, improves voiding function, and decreases symptoms of bladder outlet obstruction, researchers at the University of British Columbia in Vancouver conclude.

Next post in News